![](https://www.soutocorrea.com.br/wp-content/uploads/2022/11/thumb_life-sciences.jpg)
Client Alert
02/12/2022
ANVISA opens public consultation aiming at speeding up the approval of clinical trials for rare diseases
On 09/14/2022, ANVISA’s Board of Directors approved a Public Consultation to review the rule that sets forth mandatory pre-submission meetings for clinical trials under the current wording of RCD 205/2017.